Randomized trial demonstrates structural insights of glycoprotein B in herpes simplex virus, suggesting improved vaccine strategies.
Glycoprotein B (gB) of herpesviruses mediates membrane fusion with host cells during viral entry. Stabilizing gB in its prefusion conformation is a primary strategy for vaccine development. While prefusion-like gB structures of several human herpesviruses have been solved, the native conformational landscape and structural dynamics of gB remain largely unknown. Here, we report cryo–electron microscopy structures of herpes simplex virus type 1 (HSV-1) gB from virions, revealing a predominant prefusion state and a minor population of an intermediate, primed state. Unique to α-herpesviruses, a tethering helix cross-links adjacent protomers and stabilizes these conformations. A further downstream intermediate we named as the deep-primed state was captured in a mutant and showed that structural changes in the central helices drive the disengagement of the fusion loops from the membrane-proximal regions, priming gB for membrane insertion. Leveraging these structural insights, we engineered gB mutants locked in distinct conformational states. Our findings provide an atlas for designing gB-based vaccines more closely mimicking the infectious virus.
No takes yet. Share an insight, caveat, or question.
Mou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: